Current Edition Of Indian Pharmacopoeia Link -

The IP 2022 has actively worked to reduce for drugs exported to regulated markets. While not identical, IP standards are increasingly harmonized with BP and USP, especially for common excipients and finished products.

The IPC has made it clear: there is no alternative to the current edition. Pharmaceutical companies must regularly visit the ipc.gov.in portal for corrigenda and new addenda notifications. In the world of drug regulation, being one edition behind is equivalent to being non-compliant. current edition of indian pharmacopoeia